RESUMEN
A multitude of molecules have been identified over the past few years that promote neurite outgrowth in vitro. The concept that these molecules work mainly by providing an adhesive surface for neuronal growth cones has been challenged by evidence from recent experiments. Some of the substrate molecules have diverse actions on cell migration and neurite growth. In addition, there is now evidence that there are molecules that specifically inhibit growth cone locomotion. This has given rise to the hypothesis that growth cones integrate a variety of growth-promoting and inhibitory signals and translate them into directed locomotion.
Asunto(s)
Neuritas/fisiología , Neuronas/citología , Animales , Adhesión Celular , Movimiento Celular , Matriz Extracelular/fisiología , HumanosRESUMEN
A series of specific macromolecules (tetanus toxin, cholera toxin, nerve growth factor [NGF], and several lectins) have been shown to be transported retrogradely with high selectivity from terminals to cell bodies in various types of neurons. Under identical experimental conditions (low protein concentrations injected), most other macromolecules, e.g. horseradish peroxidase (HRP), albumin, ferritin, are not transported in detectable amounts. In the present EM study, we demonstrate selective binding of tetanus toxin to the surface membrane of nerve terminals, followed by uptake and subsequent retorgrade axonal transport. Tetanus toxin or albumin was adsorbed to colloidal gold particles (diam 200 A). The complex was shown to be stable and well suited as an EM tracer. 1-4 h after injection into the anterior eye chamber of adult rats, tetanus toxin-gold particles were found to be selectively associated with membranes of nerve terminals and preterminal axons. Inside terminals and axons, the tracer was localized mainly in smooth endoplasmic reticulum (SER)-like membrane compartments. In contrast, association of albumin-gold complexes with nervous structures was never observed, in spite of extensive uptake into fibroblasts. Electron microscope and biochemical experiments showed selective retrograde transport of tetanus toxin-gold complexes to the superior cervical ganglion. Specific binding to membrane components at nerve terminals and subsequent internalization and retrograde transport may represent an important pathway for macromolecules carrying information from target organs to the perikarya of their innervating neurons.
Asunto(s)
Iris/inervación , Terminaciones Nerviosas/metabolismo , Toxina Tetánica/metabolismo , Animales , Axones , Transporte Biológico , Membrana Celular/metabolismo , Coloides , Retículo Endoplásmico/metabolismo , Femenino , Ganglios/metabolismo , Oro , Terminaciones Nerviosas/ultraestructura , Neuronas/metabolismo , RatasRESUMEN
Lack of neurite growth in optic nerve explants in vitro has been suggested to be due to nonpermissive substrate properties of higher vertebrate central nervous system (CNS) white matter. We have searched for surface components in CNS white matter, which would prevent neurite growth. CNS, but not peripheral nervous system (PNS) myelin fractions from rat and chick were highly nonpermissive substrates in vitro. We have used an in vitro spreading assay with 3T3 cells to quantify substrate qualities of membrane fractions and of isolated membrane proteins reconstituted in artificial lipid vesicles. CNS myelin nonpermissiveness was abolished by treatment with proteases and was not associated with myelin lipid. Nonpermissive proteins were found to be membrane bound and yielded highly nonpermissive substrates upon reconstitution into liposomes. Size fractionation of myelin protein by SDS-PAGE revealed two highly nonpermissive minor protein fractions of Mr 35 and 250-kD. Removal of 35- and of 250-kD protein fractions yielded a CNS myelin protein fraction with permissive substrate properties. Supplementation of permissive membrane protein fractions (PNS, liver) with low amounts of 35- or of 250-kD CNS myelin protein was sufficient to generate highly nonpermissive substrates. Inhibitory 35- and 250-kD proteins were found to be enriched in CNS white matter and were found in optic nerve cell cultures which contained highly nonpermissive, differentiated oligodendrocytes. The data presented demonstrate the existence of membrane proteins with potent nonpermissive substrate properties. Distribution and properties suggest that these proteins might play a crucial inhibitory role during development and regeneration in CNS white matter.
Asunto(s)
Axones/fisiología , Sistema Nervioso Central/análisis , Proteínas de la Membrana/análisis , Vaina de Mielina/análisis , Proteínas del Tejido Nervioso/análisis , Animales , Adhesión Celular , Línea Celular , Sistema Nervioso Central/fisiología , Pollos , Electroforesis en Gel de Poliacrilamida , Fibroblastos , Proteínas de la Membrana/fisiología , Regeneración Nerviosa , Proteínas del Tejido Nervioso/fisiología , Nervios Periféricos/análisis , Nervios Periféricos/fisiología , Ranidae , Ratas , TruchaRESUMEN
The uptake and retrograde transport of noradrenaline (NA) within the axons of sympathetic neurons was investigated in an in vitro system. Dissociated neurons from the sympathetic ganglia of newborn rats were cultured for 3-6 wk in the absence of non-neuronal cells in a culture dish divided into three chambers. These allowed separate access to the axonal networks and to their cell bodies of origin. [3H]NA (0.5 X 10(-6) M), added to the axon chambers, was taken up by the desmethylimipramine- and cocaine-sensitive neuronal amine uptake mechanisms, and a substantial part was rapidly transported retrogradely along the axons to the nerve cell bodies. This transport was blocked by vinblastine or colchicine. In contrast with the storage of [3H]NA in the axonal varicosities, which was totally prevented by reserpine (a drug that selectively inactivates the uptake of NA into adrenergic storage vesicles), the retrograde transport of [3H]NA was only slightly diminished by reserpine pretreatment. Electron microscopic localization of the NA analogue 5-hydroxydopamine (5-OHDA) indicated that mainly large dense-core vesicles (700-1,200-A diam) are the transport compartment involved. Whereas the majority of small and large vesicles lost their amine dense-core and were resistant to this drug. It, therefore, seems that these vesicles maintained the amine uptake and storage mechanisms characteristic for adrenergic vesicles, but have lost the sensitivity of their amine carrier for reserpine. The retrograde transport of NA and 5-OHDA probably reflects the return of used synaptic vesicle membrane to the cell body in a form that is distinct from the membranous cisternae and prelysosomal structures involved in the retrograde axonal transport of extracellular tracers.
Asunto(s)
Transporte Axonal , Ganglios Simpáticos/metabolismo , Neuronas/metabolismo , Norepinefrina/metabolismo , Reserpina/farmacología , Animales , Transporte Axonal/efectos de los fármacos , Microscopía Electrónica , Neuronas/efectos de los fármacos , Neuronas/ultraestructura , Ratas , Tranilcipromina/farmacologíaRESUMEN
The fate of tetanus toxin (mol wt 150,000) subsequent to its retrograde axonal transport in peripheral sympathetic neurons of the rat was studied by both electron microscope autoradiography and cytochemistry using toxin-horseradish peroxidase (HRP) coupling products, and compared to that of nerve growth factor (NGF), cholera toxin, and the lectins wheat germ agglutinin (WGA), phytohaemagglutinin (PHA), and ricin. All these macromolecules are taken up by adrenergic nerve terminals and transported retrogradely in a selective, highly efficient manner. This selective uptake and transport is a consequence of the binding of these macromolecules to specific receptive sites on the nerve terminal membrane. All these ligands are transported in the axons within smooth vesicles, cisternae, and tubules. In the cell bodies these membrane compartments fuse and most of the transported macromolecules are finally incorporated into lysosomes. The cell nuclei, the parallel golgi cisternae, and the extracellular space always remain unlabeled. In case the tetanus toxin, however, a substantial fraction of the labeled material appears in presynaptic cholinergic nerve terminals which innervate the labeled ganglion cells. In these terminals tetanus toxin-HRP is localized in 500-1,000 A diam vesicles. In contrast, such a retrograde transsynaptic transfer is not at all or only very rarely detectable after retrograde transport of cholera toxin, NGF, WGA, PHA, or ricin. An atoxic fragment of the tetanus toxin, which contains the ganglioside-binding site, behaves like intact toxin. With all these macromolecules, the extracellular space and the glial cells in the ganglion remain unlabeled. We conclude that the selectivity of this transsynaptic transfer of tetanus toxin is due to a selective release of the toxin from the postsynaptic dendrites. This release is immediately followed by an uptake into the presynaptic terminals.
Asunto(s)
Transporte Axonal , Sinapsis/metabolismo , Toxina Tetánica/metabolismo , Fibras Adrenérgicas/metabolismo , Animales , Autorradiografía , Axones/metabolismo , Toxina del Cólera/metabolismo , Femenino , Ganglios Simpáticos/metabolismo , Histocitoquímica , Lectinas/metabolismo , Cuello , Factores de Crecimiento Nervioso/metabolismo , Ratas , Ricina/metabolismoRESUMEN
Differentiated oligodendrocytes and central nervous system (CNS) myelin are nonpermissive substrates for neurite growth and for cell attachment and spreading. This property is due to the presence of membrane-bound inhibitory proteins of 35 and 250 kD and is specifically neutralized by monoclonal antibody IN-1 (Caroni, P., and M. E. Schwab. 1988. Neuron. 1:85-96). Using rat optic nerve explants, CNS frozen sections, cultured oligodendrocytes or CNS myelin, we show here that highly invasive CNS tumor line (C6 glioblastoma) was not inhibited by these myelin-associated inhibitory components. Lack of inhibition was due to a specific mechanism as the metalloenzyme blocker 1,10-phenanthroline and two synthetic dipeptides containing metalloprotease-blocking sequences (gly-phe, tyr-tyr) specifically impaired C6 cell spreading on CNS myelin. In the presence of these inhibitors, C6 cells were affected by the IN-1-sensitive inhibitors in the same manner as control cells, e.g., 3T3 fibroblasts or B16 melanomas. Specific blockers of the serine, cysteine, and aspartyl protease classes had no effect. C6 cell spreading on inhibitor-free substrates such as CNS gray matter, peripheral nervous system myelin, glass, or poly-D-lysine was not sensitive to 1,10-phenanthroline. The nonpermissive substrate properties of CNS myelin were strongly reduced by incubation with a plasma membrane fraction prepared from C6 cells. This reduction was sensitive to the same inhibitors of metalloproteases. In our in vitro model for CNS white matter invasion, cell infiltration of optic nerve explants, which occurred with C6 cells but not with 3T3 fibroblasts or B16 melanomas, was impaired by the presence of the metalloprotease blockers. These results suggest that C6 cell infiltrative behavior in CNS white matter in vitro occurs by means of a metalloproteolytic activity, which probably acts on the myelin-associated inhibitory substrates.
Asunto(s)
Encéfalo/patología , Glioma/patología , Metaloendopeptidasas/fisiología , Animales , Membrana Celular/fisiología , Movimiento Celular , Técnicas In Vitro , Melanoma Experimental/patología , Metaloendopeptidasas/antagonistas & inhibidores , Modelos Biológicos , Vaina de Mielina/fisiología , Oligodendroglía/fisiología , Nervio Óptico/patología , Fenantrolinas/farmacología , RatasRESUMEN
Invasive glioma cells migrate preferentially along central nervous system (CNS) white matter fiber tracts irrespective of the fact that CNS myelin contains proteins that inhibit cell migration and neurite outgrowth. Previous work has demonstrated that to migrate on a myelin substrate and to overcome its inhibitory effect, rat C6 and human glioblastoma cells require a membrane-bound metalloproteolytic activity (C6-MP) which shares several biochemical and pharmacological characteristics with MT1-MMP. We show now that MT1-MMP is expressed on the surface of rat C6 glioblastoma cells and is coenriched with C6-MP activity. Immunodepletion of C6-MP activity is achieved with an anti-MT1-MMP antibody. These data suggest that MT1-MMP and the C6-MP are closely related or identical. When mouse 3T3 fibroblasts were transfected with MT1-MMP they acquired the ability to spread and migrate on the nonpermissive myelin substrate and to infiltrate into adult rat optic nerve explants. MT1-MMP-transfected fibroblasts and C6 glioma cells were able to digest bNI-220, one of the most potent CNS myelin inhibitory proteins. Plasma membranes of both MT1-MMP-transfected fibroblasts and C6 glioma cells inactivated inhibitory myelin extracts, and this activity was sensitive to the same protease inhibitors. Interestingly, pretreatment of CNS myelin with gelatinase A/MMP-2 could not inactivate its inhibitory property. These data imply an important role of MT1-MMP in spreading and migration of glioma cells on white matter constituents in vitro and point to a function of MT1-MMP in the invasive behavior of malignant gliomas in the CNS in vivo.
Asunto(s)
Sistema Nervioso Central/patología , Glioma/patología , Metaloendopeptidasas/metabolismo , Invasividad Neoplásica , Células 3T3 , Animales , Anticuerpos Monoclonales/inmunología , Extractos Celulares , Membrana Celular/metabolismo , Movimiento Celular , Activación Enzimática , Gelatinasas/metabolismo , Glioblastoma/patología , Humanos , Metaloproteinasa 14 de la Matriz , Metaloproteinasa 2 de la Matriz , Metaloproteinasas de la Matriz Asociadas a la Membrana , Metaloendopeptidasas/antagonistas & inhibidores , Metaloendopeptidasas/genética , Ratones , Vaina de Mielina/fisiología , Nervio Óptico/fisiología , Inhibidores de Proteasas/farmacología , Ratas , Transfección , Células Tumorales CultivadasRESUMEN
A myelin-associated protein from the central nervous system, the neurite growth inhibitor NI-35, inhibits regeneration of lesioned neuronal fiber tracts in vivo and growth of neurites in vitro. Growth cones of cultured rat dorsal root ganglion neurons arrested their growth and collapsed when exposed to liposomes containing NI-35. Before morphological changes, the concentration of free intracellular calcium ([Ca2+]i) showed a rapid and large increase in growth cones exposed to liposomes containing NI-35. Neither an increase in [Ca2+]i nor collapse of growth cones was detected in the presence of antibodies to NI-35. Dantrolene, an inhibitor of calcium release from caffeine-sensitive intracellular calcium stores, protected growth cones from collapse evoked by NI-35. Depletion of these caffeine-sensitive intracellular calcium stores prevented the increase in [Ca2+]i evoked by NI-35. The NI-35-evoked cascade of intracellular messengers that mediates collapse of growth cones includes the crucial step of calcium release from intracellular stores.
Asunto(s)
Calcio/metabolismo , Ganglios Espinales/fisiología , Inhibidores de Crecimiento/farmacología , Fibras Nerviosas/fisiología , Neuronas/fisiología , Animales , Cafeína/farmacología , Células Cultivadas , Portadores de Fármacos , Fura-2 , Cinética , Liposomas , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/ultraestructura , Neuronas/efectos de los fármacos , Neuronas/ultraestructura , RatasRESUMEN
CNS white matter from higher vertebrates and cultured differentiated oligodendrocytes are nonpermissive substrates for neurite growth and fibroblast spreading. Membrane proteins of 35 kd and 250 kd with highly nonpermissive substrate properties could be extracted from CNS myelin fractions. Monoclonal antibodies were raised against these proteins: IN-1 and IN-2 bound both to the 35 kd and 250 kd inhibitors and to the surface to differentiated cultured oligodendrocytes. Adsorption of nonpermissive CNS myelin or nonpermissive oligodendrocytes with either antibody markedly improved their substrate properties. Optic nerve explants injected with IN-1 or IN-2 allowed axon ingrowth of cocultured sensory and sympathetic neurons. We conclude that the nonpermissive substrate properties of CNS white matter are due to these membrane proteins on the surface of differentiated oligodendrocytes and to their in vivo product, myelin.
Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Encéfalo/inmunología , Inhibidores de Crecimiento/inmunología , Vaina de Mielina/inmunología , Nervio Óptico/inmunología , Animales , Anticuerpos Monoclonales/farmacología , Encéfalo/citología , Inhibidores de Crecimiento/farmacología , Ratones , Peso Molecular , Nervio Óptico/citología , RatasRESUMEN
The MAG-deficient mouse was used to test whether MAG acts as a significant inhibitor of axonal regeneration in the adult mammalian CNS, as suggested by cell culture experiments. Cell spreading, neurite elongation, or growth cone collapse of different cell types in vitro was not significantly different when myelin preparations or optic nerve cryosections from either MAG-deficient or wild-type mice were used as a substrate. More importantly, the extent of axonal regrowth in lesioned optic nerve and corticospinal tract in vivo was similarly poor in MAG-deficient and wild-type mice. However, axonal regrowth increased significantly and to a similar extent in both genotypes after application of the IN-1 antibody directed against the neurite growth inhibitors NI-35 and NI-250. These observations do not support the view that MAG is a significant inhibitor of axonal regeneration in the adult CNS.
Asunto(s)
Axones/fisiología , Sistema Nervioso Central/fisiología , Glicoproteína Asociada a Mielina/fisiología , Regeneración Nerviosa , Inhibición Neural/fisiología , Células 3T3 , Animales , Cerebelo/citología , Ganglios Espinales/citología , Inhibidores de Crecimiento/antagonistas & inhibidores , Ratones , Ratones Mutantes , Proteínas de la Mielina/farmacología , Glicoproteína Asociada a Mielina/deficiencia , Glicoproteína Asociada a Mielina/farmacología , Neuritas/fisiología , Neuronas/efectos de los fármacos , Neuronas/fisiología , Nervio Óptico/citología , Células PC12 , Tractos Piramidales/citología , Ratas , Células Tumorales CultivadasRESUMEN
The present study describes in primates the effects of a spinal cord injury on the number and size of the neurons in the magnocellular part of the red nucleus (RNm), the origin of the rubrospinal tract, and evaluates whether a neutralization of Nogo-A reduces the lesioned-induced degenerative processes observed in RNm. Two groups of monkeys were subjected to unilateral section of the spinal cord affecting the rubrospinal tract; one group was subsequently treated with an antibody neutralizing Nogo-A; the second group received a control antibody. Intact animals were also included in the study. Counting neurons stained with a monoclonal antibody recognizing non-phosphorylated epitopes on neurofilaments (SMI-32) indicated that their number in the contralesional RNm was consistently inferior to that in the ipsilesional RNm, in a proportion amounting up to 35%. The lesion also induced shrinkage of the soma of the neurons detected in the contralesional RNm. Infusing an anti-Nogo-A antibody at the site of the lesion did not increase the proportion of SMI-32 positive rubrospinal neurons in the contralesional RNm nor prevent shrinkage.
Asunto(s)
Anticuerpos Monoclonales/farmacología , Proteínas de la Mielina/antagonistas & inhibidores , Neuronas/patología , Tractos Piramidales/patología , Núcleo Rojo/patología , Traumatismos de la Médula Espinal/patología , Animales , Axotomía , Vértebras Cervicales , Lateralidad Funcional/fisiología , Humanos , Macaca , Proteínas de Neurofilamentos/efectos de los fármacos , Proteínas NogoRESUMEN
QUESTIONS UNDER STUDY: This study represents a first attempt at estimating Swiss resource allocation to brain research including both public and private spending. METHODS: In order to estimate public spending (by governments and charities) a survey was conducted to evaluate the way brain research is funded across Europe and especially in Switzerland. Industry funding was measured using different approaches including a survey of pharmaceutical expenditures and the costs of developing new drugs. RESULTS: Private spending is at a reasonable level because a highly developed Swiss pharmaceutical industry invests significantly in this branch of science. However, public spending is at a low level compared to other European countries, although Switzerland is the only European country where the total funding per capita exceeds that of US funding. CONCLUSIONS: A detailed investigation of Swiss resource allocation to different branches of biomedical research is warranted. Brain research should be an important part of such a study. The United States and the European Union have selected brain research as one of their priority areas within health related research. The present figures indicate that this may also be justified in Switzerland.
Asunto(s)
Enfermedades del Sistema Nervioso/economía , Neurociencias/economía , Apoyo a la Investigación como Asunto , Recolección de Datos , Diseño de Fármacos , Humanos , Asignación de Recursos , SuizaRESUMEN
Anatomical plasticity and functional recovery after lesions of the rodent corticospinal tract (CST) decrease postnatally in parallel with myelin formation. Myelin-associated neurite growth inhibitory proteins prevent regenerative fiber growth, but whether they also prevent reactive sprouting of unlesioned fibers is less clear. Here we show that after unilateral CST lesion in the adult rat brainstem, both intact and lesioned tracts show topographically appropriate sprouting after treatment with a monoclonal antibody that neutralizes these inhibitory proteins. Antibody-treated animals showed full recovery in motor and sensory tests, whereas untreated lesioned rats exhibited persistent severe deficits. Neutralization of myelin-associated neurite growth inhibitors thus restores in adults the structural plasticity and functional recovery normally found only at perinatal ages.
Asunto(s)
Enfermedades del Sistema Nervioso Central/fisiopatología , Inhibidores de Crecimiento/fisiología , Neuritas/fisiología , Plasticidad Neuronal/fisiología , Tractos Piramidales/fisiopatología , Animales , Anticuerpos Monoclonales/farmacología , Actividad Motora/efectos de los fármacos , Vaina de Mielina/fisiología , Regeneración Nerviosa/fisiología , Plasticidad Neuronal/efectos de los fármacos , Tractos Piramidales/efectos de los fármacos , Ratas , Ratas Endogámicas Lew , Sensación/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacosRESUMEN
The adult central nervous system (CNS) of higher vertebrates displays a limited ability for self repair after traumatic injuries, leading to lasting functional deficits [1]. Small injuries can result in transient impairments, but the mechanisms of recovery are poorly understood [2]. At the cortical level, rearrangements of the sensory and motor representation maps often parallel recovery [3,4]. In the sensory system, studies have shown that cortical and subcortical mechanisms contribute to map rearrangements [5,6], but for the motor system the situation is less clear. Here we show that large-scale structural changes in the spared rostral part of the spinal cord occur simultaneously with shifts of a hind-limb motor cortex representation after traumatic spinal-cord injury. By intracortical microstimulation, we defined a cortical area that consistently and exclusively yielded hind-limb muscle responses in normal adult rats. Four weeks after a bilateral transsection of the corticospinal tract (CST) in the lower thoracic spinal cord, we again stimulated this cortical field and found forelimb, whisker, and trunk responses, thus demonstrating reorganization of the cortical motor representation. Anterograde tracing of corticospinal fibers originating from this former hind-limb area revealed that sprouting greatly increased the normally small number of collaterals that lead into the cervical spinal cord rostral to the lesion. We conclude that the corticospinal motor system has greater potential to adapt structurally to lesions than was previously believed and hypothesize that this spontaneous growth response is the basis for the observed motor representation rearrangements and contributes to functional recovery after incomplete lesions.
Asunto(s)
Vértebras Cervicales/fisiopatología , Potenciales Evocados Motores/fisiología , Fibras Nerviosas/fisiología , Tractos Piramidales/fisiopatología , Traumatismos de la Médula Espinal/fisiopatología , Vértebras Torácicas/lesiones , Animales , Vértebras Cervicales/patología , Estimulación Eléctrica , Femenino , Miembro Anterior/fisiopatología , Miembro Posterior/fisiopatología , Corteza Motora/fisiopatología , Músculo Esquelético/fisiopatología , Ratas , Ratas Endogámicas LewRESUMEN
Current neuromodulatory strategies to enhance motor recovery after stroke often target large brain areas non-specifically and without sufficient understanding of their interaction with internal repair mechanisms. Here we developed a novel therapeutic approach by specifically activating corticospinal circuitry using optogenetics after large strokes in rats. Similar to a neuronal growth-promoting immunotherapy, optogenetic stimulation together with intense, scheduled rehabilitation leads to the restoration of lost movement patterns rather than induced compensatory actions, as revealed by a computer vision-based automatic behavior analysis. Optogenetically activated corticospinal neurons promote axonal sprouting from the intact to the denervated cervical hemi-cord. Conversely, optogenetically silencing subsets of corticospinal neurons in recovered animals, results in mistargeting of the restored grasping function, thus identifying the reestablishment of specific and anatomically localized cortical microcircuits. These results provide a conceptual framework to improve established clinical techniques such as transcranial magnetic or transcranial direct current stimulation in stroke patients.
Asunto(s)
Corteza Motora/fisiopatología , Tractos Piramidales/fisiopatología , Accidente Cerebrovascular/terapia , Estimulación Transcraneal de Corriente Directa/métodos , Algoritmos , Animales , Axones/fisiología , Fenómenos Biomecánicos/fisiología , Femenino , Humanos , Regeneración Nerviosa/fisiología , Neuronas/fisiología , Optogenética/métodos , Ratas Long-Evans , Recuperación de la Función/fisiología , Accidente Cerebrovascular/fisiopatologíaRESUMEN
Axons often respond to lesions by spontaneous sprouting which, in the PNS, can be followed by elongation over long distances. In contrast, in the CNS, regenerative axon growth in most fibre systems subsides after 0.5-1.0 mm. The observation that an identical situation can be found in tissue culture in the presence of trophic factors argued for the existence of inhibitory mechanisms within the CNS tissue. Detailed cell biological and biochemical studies have provided evidence for two membrane proteins localized selectively in oligodendrocytes and CNS myelin and which exert a powerful inhibitory effect on neurite growth. Antibodies raised against these neurite growth inhibitors (NI-35 and NI-250) and applied to rats with complete transections of the corticospinal tract (CST) resulted in CST axon regeneration over five to ten mm from the lesion site within two to three weeks. Analogous results were obtained in rats lacking myelin and oligodendrocytes in the spinal cord. During development, the 'fuzzy' appearance of the CST grown in the absence of oligodendrocytes or in the presence of anti-inhibitor antibodies indicates a boundary and guidance function of these inhibitors for late growing CNS tracts.
Asunto(s)
Axones/fisiología , Sistema Nervioso Central/fisiología , Inhibidores de Crecimiento/fisiología , Vaina de Mielina/fisiología , Regeneración Nerviosa , Animales , Sistema Nervioso Central/ultraestructura , Oligodendroglía/fisiología , RatasRESUMEN
Axons undergo Wallerian degeneration (WD) distal to a point of injury. In the lesioned PNS, WD may be followed by successful axonal regeneration and functional recovery. However, in the lesioned mammalian CNS, there is no significant axonal regeneration. Myelin-associated proteins (MAPs) have been shown to play significant roles in preventing axonal regeneration in the CNS. Since relatively little is known about such events in human CNS pathologies, we performed an immunohistochemical investigation on the temporal changes of four MAPs during WD in post-mortem spinal cords of 22 patients who died 2 days to 30 years after either cerebral infarction or traumatic spinal cord injury. In contrast to experimental studies in rats, the loss of myelin sheaths is greatly delayed in humans and continues slowly over a number of years. However, in agreement with animal data, a sequential loss of myelin proteins was found which was dependent on their location within the myelin sheath. Myelin proteins situated on the peri-axonal membrane were the first to be lost, the time course correlating with the loss of axonal markers. Proteins located within compact myelin or on the outer myelin membrane were still detectable 3 years after injury in degenerating fibre tracts, long after the disappearance of the corresponding axons. The persistence of axon growth-inhibitory proteins such as NOGO-A in degenerating nerve fibre tracts may contribute to the maintenance of an environment that is hostile to axon regeneration, long after the initial injury. The present data highlight the importance of correlating the well documented, lesion-induced changes that take place in controlled laboratory investigations with those that take place in the clinical domain.
Asunto(s)
Proteínas de la Mielina/metabolismo , Médula Espinal/metabolismo , Degeneración Walleriana/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Astrocitos/patología , Recuento de Células , Infarto Cerebral/complicaciones , Infarto Cerebral/metabolismo , Infarto Cerebral/patología , Humanos , Persona de Mediana Edad , Fibras Nerviosas/metabolismo , Fibras Nerviosas/patología , Oligodendroglía/patología , Médula Espinal/patología , Traumatismos de la Médula Espinal/complicaciones , Traumatismos de la Médula Espinal/metabolismo , Traumatismos de la Médula Espinal/patología , Factores de Tiempo , Degeneración Walleriana/etiología , Degeneración Walleriana/patologíaRESUMEN
Malignant gliomas infiltrate the brain preferentially along myelinated fiber tracts. Central nervous system (CNS) myelin, however, contains inhibitory proteins that block axon regeneration, neurite outgrowth, and cell spreading of astrocytes and fibroblasts. We tested 5 human brain tumor cell lines, 1 rat brain tumor cell line, and 29 short-term cultured specimens from human brain tumors for their ability to spread and migrate on a CNS myelin substrate. Low-grade and pilocytic astrocytoma, ependymoma, medulloblastoma, and meningioma cell lines as well as primary cultures were strongly sensitive to the inhibitory proteins present in the CNS myelin. In contrast, glioblastomas, anaplastic astrocytomas, and oligodendrogliomas were able to spread and migrate on CNS myelin-coated culture dishes, demonstrating that within the gliomas, the ability to overcome the inhibitory effects of the CNS myelin is correlated with the grade of malignancy of the original tumor. Cell spreading of glioblastomas and anaplastic astrocytomas specifically on a CNS myelin substrate was strongly inhibited by the metalloprotease blocker O-phenanthroline and the peptide derivative carbobenzoxy-Phe-Ala-Phe-Tyr-amide, whereas blockers for serine, aspartyl, and cysteine proteases had no effect. Enzymatic peptide degradation assays revealed the presence of a phosphoramidon-sensitive and thiorphan-insensitive metalloproteolytic activity in the plasma membranes of high-grade glioma cells. These results suggest a crucial involvement of a membrane-bound metalloendoprotease in the process of invasive migration of malignant gliomas along CNS white matter fiber tracts.
Asunto(s)
Astrocitoma/secundario , Neoplasias Encefálicas/patología , Ependimoma/secundario , Meduloblastoma/secundario , Proteínas de la Mielina/fisiología , Vaina de Mielina , Animales , Astrocitoma/metabolismo , Neoplasias Encefálicas/metabolismo , Adhesión Celular , Movimiento Celular , Ependimoma/metabolismo , Glioblastoma/metabolismo , Glioblastoma/secundario , Humanos , Meduloblastoma/metabolismo , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patología , Meningioma/metabolismo , Meningioma/secundario , Metaloendopeptidasas/antagonistas & inhibidores , Invasividad Neoplásica , RatasRESUMEN
C6 rat glioblastoma cells are able to attach to and to spread on culture dishes which are coated with purified central nervous system myelin, in contrast to normal astrocytes, fibroblasts or neurons which adhere poorly and are unable to spread on this substrate. The metalloprotease blockers o-phenanthroline and a newly developed oligopeptide could specifically inhibit C6 cell spreading on central nervous system myelin, suggesting a crucial role for a metalloprotease. Here we characterize this metalloproteolytic activity of C6 cells using a peptide degradation assay with the iodinated tetrapeptide carbobenzoxy-Phe-Ala-Phe-125I-Tyr-amide as a substrate. Purified, salt-washed C6 plasma membranes cleaved the peptide between alanine and phenylalanine, an effect which is strongly inhibited by o-phenanthroline, but not by thiol-blocking agents or aspartic and serine protease inhibitors. The metalloendoprotease is highly sensitive to phosphoramidon but insensitive to thiorphan. The enzyme is tightly bound to the plasma membrane but not G protein-phosphatidylinositol linked. It can be solubilized in part by the detergents 3-(3-cholamidopropyldimethylamino)-1-propanesulfonate or Triton X-114. Gel filtration chromatography using the Triton X-114-solubilized proteins or the proteins removed by a short trypsin treatment revealed a molecular weight range for the C6 enzyme of 60,000-100,000. Polymerase chain reaction with primers corresponding to endopeptidase 24.11 or to the highly conserved motif of the "astacin family" showed that both enzymes were not detectable in the C6 glioblastoma cells.